Astrazeneca PLC Company Profile (NYSE:AZN)

About Astrazeneca PLC

Astrazeneca PLC logoAstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas. The Company has its operations in over 100 countries. The Company's pipeline includes over 150 projects of which approximately 125 are in the clinical phase of development. The Company is developing a Toll-like receptor 9 (TLR-9) receptor agonist aimed at producing long-term benefit in asthma by addressing imbalances in the immune system. AstraZeneca offers various products, including Accolate, Rhinocort, Bricanyl Turbuhaler, Rhinocort, Symbicort pMDI, Crestor, Seloken/Toprol-XL, Brilinta/Brilique (ticagrelor), Bydureon, Xigduo XR, Kombiglyze XR and metformin XR, among others.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: AZN
  • CUSIP:
Key Metrics:
  • Previous Close: $33.05
  • 50 Day Moving Average: $33.37
  • 200 Day Moving Average: $30.65
  • 52-Week Range: $26.97 - $35.04
  • Trailing P/E Ratio: 37.55
  • Foreward P/E Ratio: 17.03
  • P/E Growth: -11.06
  • Market Cap: $83.14B
  • Outstanding Shares: 2,530,000,000
  • Beta: 0.77
Profitability:
  • Net Margins: 9.23%
  • Return on Equity: 28.02%
  • Return on Assets: 7.83%
Debt:
  • Debt-to-Equity Ratio: 1.07%
  • Current Ratio: 0.93%
  • Quick Ratio: 0.76%
Additional Links:
Companies Related to Astrazeneca PLC:

Analyst Ratings

Consensus Ratings for Astrazeneca PLC (NYSE:AZN) (?)
Ratings Breakdown: 2 Sell Ratings, 8 Hold Ratings, 10 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Hold (Score: 2.48)
Consensus Price Target: $37.46 (13.99% upside)

Analysts' Ratings History for Astrazeneca PLC (NYSE:AZN)
Show:
DateFirmActionRatingPrice TargetDetails
9/28/2016Shore CapitalReiterated RatingHoldView Rating Details
9/28/2016Deutsche Bank AGReiterated RatingBuyView Rating Details
9/23/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
9/23/2016Piper Jaffray Cos.Initiated CoverageOverweightView Rating Details
9/13/2016BNP ParibasDowngradeOutperform -> NeutralView Rating Details
9/12/2016Jefferies GroupUpgradeHold -> BuyView Rating Details
9/11/2016Berenberg BankReiterated RatingBuyView Rating Details
9/8/2016Bank of America Corp.Set Price TargetBuy$41.40View Rating Details
8/29/2016ArgusUpgradeHold -> Buy$38.00View Rating Details
8/26/2016Beaufort SecuritiesReiterated RatingHoldView Rating Details
8/8/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details
8/8/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
6/16/2016Leerink SwannReiterated RatingHold$34.00View Rating Details
5/27/2016Goldman Sachs Group Inc.Reiterated RatingSellView Rating Details
2/28/2016Drexel HamiltonInitiated CoverageBuyView Rating Details
2/8/2016HSBCDowngradeBuy -> HoldView Rating Details
2/5/2016Sanford C. BernsteinLower Price Target$34.00 -> $32.00View Rating Details
1/26/2016Oddo SecuritiesUpgradeNeutral -> Top PickView Rating Details
1/19/2016Barclays PLCUpgradeUnderweight -> Equal Weight$44.00 -> $50.00View Rating Details
1/13/2016Credit Suisse Group AGReiterated RatingUnderperformView Rating Details
12/30/2015Morgan StanleyReiterated RatingBuyView Rating Details
11/2/2015Nordea Equity ResearchDowngradeBuy -> HoldView Rating Details
9/18/2015Bryan, Garnier & CoUpgradeNeutral -> BuyView Rating Details
7/31/2015S&P Equity ResearchUpgradeBuy$38.00View Rating Details
7/31/2015SwedbankUpgradeNeutral -> BuyView Rating Details
6/2/2015Kepler Capital MarketsReiterated RatingReduceView Rating Details
4/16/2015Liberum CapitalReiterated RatingBuyView Rating Details
4/15/2015Societe GeneraleInitiated CoverageBuyView Rating Details
2/6/2015Panmure GordonReiterated RatingBuyView Rating Details
2/6/2015DanskeDowngradeSellView Rating Details
2/3/2015SEB Equity ResearchUpgradeHold -> BuyView Rating Details
(Data available from 10/1/2014 forward)

Earnings

Earnings History for Astrazeneca PLC (NYSE:AZN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/28/2016Q216$0.76$0.83$5.56 billion$5.60 billionViewListenView Earnings Details
4/29/2016Q1$0.60$0.51$5.96 billion$6.12 billionViewListenView Earnings Details
2/4/2016Q415$0.88$0.94$6.27 billion$6.40 billionViewN/AView Earnings Details
11/5/2015Q315$0.51$1.03$5.90 billion$5.85 billionViewN/AView Earnings Details
7/30/2015Q2$1.08$1.21$6.02 billion$5.84 billionViewListenView Earnings Details
4/24/2015Q1$1.07$1.08$5.87 billion$6.06 billionViewN/AView Earnings Details
2/5/2015Q314$0.85$0.76$6.68 billion$6.68 billionViewN/AView Earnings Details
11/6/2014Q3$1.04$1.05$6.44 billion$6.54 billionViewN/AView Earnings Details
7/31/2014Q214$1.09$1.30$6.24 billion$6.45 billionViewN/AView Earnings Details
4/24/2014Q114$1.23$1.17$6.32 billion$6.42 billionViewN/AView Earnings Details
2/6/2014Q413$1.22$1.23$6.91 billion$3.84 billionViewN/AView Earnings Details
10/31/2013Q313$1.27$1.21$6.45 billion$6.25 billionViewN/AView Earnings Details
8/1/2013Q213$1.16$1.20$6.24 billion$6.23 billionViewN/AView Earnings Details
4/25/2013$1.36$1.41$6.54 billion$6.39 billionViewN/AView Earnings Details
1/31/2013Q412$1.37$1.56$7.17 billion$7.28 billionViewN/AView Earnings Details
10/25/2012$1.44$1.51ViewN/AView Earnings Details
7/26/2012$1.38$1.53ViewN/AView Earnings Details
4/26/2012$1.73$1.81ViewN/AView Earnings Details
2/2/2012$1.57$1.61ViewN/AView Earnings Details
10/27/2011$1.64$1.71ViewN/AView Earnings Details
7/28/2011$1.74$1.53ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Astrazeneca PLC (NYSE:AZN)
Current Year EPS Consensus Estimate: $2.07 EPS
Next Year EPS Consensus Estimate: $1.93 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.53$1.01$0.77
Q2 20162$0.40$0.45$0.43
Q3 20161$0.56$0.56$0.56
Q4 20161$0.60$0.60$0.60
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Astrazeneca PLC (NYSE:AZN)
Annual Dividend:$1.37
Dividend Yield:4.17%
Dividend Growth:-6.60% (3 Year Average)
Payout Ratio:78.29% (Based on Trailing 12 Months of Earnings)
66.18% (Based on Current Year Consensus EPS Estimate)
70.98% (Based on Next Year Consensus EPS Estimate)

Dividend History for Astrazeneca PLC (NYSE:AZN)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/29/2016$0.448/10/20168/12/20169/12/2016
2/5/2016$0.932/17/20162/19/20163/21/2016
2/10/2015semiannual$1.905.57%2/18/20152/20/20153/23/2015
8/1/2014semiannual$0.902.48%8/13/20148/15/20149/15/2014
2/10/2014special$1.902.79%2/19/20142/21/20143/24/2014
8/2/2013semiannual$0.903.52%8/14/20138/16/20139/16/2013
2/1/2013special$1.903.72%2/13/20132/15/20133/18/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Astrazeneca PLC (NYSE:AZN)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Astrazeneca PLC (NYSE:AZN)
DateHeadline
News IconShore Capital Reiterates Hold Rating for AstraZeneca plc (AZN) (NYSE:AZN)
crcconnection.com - September 30 at 8:58 AM
News IconAstraZeneca plc (AZN) Given "Buy" Rating at Deutsche Bank AG (NYSE:AZN)
magseriesusa.net - September 30 at 8:58 AM
uk.finance.yahoo.com logoThese two FTSE 100 dividends stars still look cheap (NYSE:AZN)
uk.finance.yahoo.com - September 29 at 8:47 AM
finance.yahoo.com logoUS FDA Approves TAGRISSO® (osimertinib) Blood-Based T790M Companion Diagnostic Test (NYSE:AZN)
finance.yahoo.com - September 29 at 8:47 AM
finance.yahoo.com logo7:03 am AstraZeneca announces that the FDA has approved a blood-based companion diagnostic for TAGRISSO (osimertinib) (NYSE:AZN)
finance.yahoo.com - September 29 at 8:47 AM
publicnow.com logo22 September 2016 Liquid biopsy: plasma ctDNA testing moves into mainstream cancer treatment (NYSE:AZN)
www.publicnow.com - September 29 at 8:47 AM
bizjournals.com logoBig Pharma takes big lease in South S.F. to consolidate California operations - San Francisco Business Times (blog) (NYSE:AZN)
www.bizjournals.com - September 28 at 8:33 AM
News IconTop Gainers of the Day: AstraZeneca PLC (NYSE:AZN) from Drug Manufacturers – Major (NYSE:AZN)
twincountynews.com - September 27 at 3:43 PM
bizjournals.com logoBig Pharma takes big lease in South S.F. to consolidate California operations (NYSE:AZN)
www.bizjournals.com - September 27 at 3:43 PM
thestreet.com logoBristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy (NYSE:AZN)
www.thestreet.com - September 27 at 8:17 AM
News IconStocks Shining Bright on Wall Street: AstraZeneca PLC (NYSE:AZN), Provectus Biopharmaceuticals, Inc. (NYSE:PVCT) - Street Wise Report (press release) (blog) (NYSE:AZN)
streetwisereport.com - September 26 at 3:50 PM
finance.yahoo.com logovTv Therapeutics Shares Initiated With Buy Rating, $13 Target (NYSE:AZN)
finance.yahoo.com - September 26 at 3:49 PM
investors.com logoUnexpected Twist: Pfizer Scraps Breakup Following Dead Allergen Merger (NYSE:AZN)
www.investors.com - September 26 at 3:49 PM
News IconIs AstraZeneca PLC(NYSE: AZN), a large market cap stock a smart buy? - The Daily Leicester (NYSE:AZN)
thedailyleicester.com - September 26 at 8:28 AM
News IconStock under Radar: Astrazeneca PLC (NYSE:AZN), Lions Gate Entertainment Corporation (NYSE:LGF) - Newburgh Press (NYSE:AZN)
newburghpress.com - September 23 at 4:07 PM
News IconStock under Radar: Astrazeneca PLC (NYSE:AZN), Lions Gate Entertainment Corporation (NYSE:LGF) - Newburgh Press (NYSE:AZN)
newburghpress.com - September 23 at 4:07 PM
zacks.com logoAstraZeneca Withdraws Cediranib Marketing Application in EU (NYSE:AZN)
www.zacks.com - September 22 at 9:36 AM
News IconAstraZeneca PLC (NYSE:AZN) from Drug Manufacturers – Major – Todays Top Gains (NYSE:AZN)
twincountynews.com - September 22 at 9:36 AM
News IconLeading stocks in today’s market: AstraZeneca PLC (NYSE:AZN) (NYSE:AZN)
twincountynews.com - September 21 at 4:38 PM
News IconAstraZeneca PLC (NYSE: AZN) - Analysis of a Large Market Cap Stock (NYSE:AZN)
www.crcconnection.com - September 21 at 4:38 PM
publicnow.com logo20 September 2016 Can ‘drag and drop’ cancer simulation speed up drug discovery? (NYSE:AZN)
www.publicnow.com - September 20 at 9:38 AM
publicnow.com logo19 September 2016 Peripheral Patients? PAD (peripheral arterial disease) Policy Initiative (NYSE:AZN)
www.publicnow.com - September 20 at 9:38 AM
publicnow.com logo19 September 2016 Patients at the core of partnership (NYSE:AZN)
www.publicnow.com - September 20 at 9:38 AM
publicnow.com logo20 September 2016 Peripheral Patients? PAD (peripheral arterial disease) Policy Initiative (NYSE:AZN)
www.publicnow.com - September 20 at 9:38 AM
publicnow.com logo20 September 2016 Patients at the core of partnership (NYSE:AZN)
www.publicnow.com - September 20 at 9:38 AM
News IconVigorous Stocks Need to Consider: AstraZeneca PLC (NYSE:AZN), Centene Corp. (NYSE:CNC) - Street Wise Report (press release) (blog) (NYSE:AZN)
streetwisereport.com - September 19 at 4:37 PM
News IconStocks Tossing up on Optimistic Data: AstraZeneca PLC (NYSE:AZN ... - Street Wise Report (press release) (blog) (NYSE:AZN)
streetwisereport.com - September 19 at 4:37 PM
News IconAstraZeneca plc (ADR) (NYSE:AZN) & CONSOL Energy Inc. (NYSE:CNX) UPDATE ON U.S STOCKS : 16 SEP 2016 - Money News (NYSE:AZN)
www.newsismoney.com - September 19 at 4:37 PM
News IconAstraZeneca PLC's (AZN): Intraday Mover - Hot Stocks Point (NYSE:AZN)
www.hotstockspoint.com - September 19 at 4:37 PM
finance.yahoo.com logoAstraZeneca Diabetes Drug Combination Positive in Phase III (NYSE:AZN)
finance.yahoo.com - September 19 at 4:37 PM
marketrealist.com logoAstraZeneca Is Taking Steps to Improve Its Position in Oncology (NYSE:AZN)
marketrealist.com - September 19 at 4:37 PM
marketrealist.com logoHow Valeant Plans to Its Fix Dermatology Portfolio (NYSE:AZN)
marketrealist.com - September 19 at 4:37 PM
News IconHC Stocks Newsbeat! AstraZeneca plc (ADR) (AZN), Pernix Therapeutics Holdings Inc (NASDAQ:PTX) - share market updates (press release) (NYSE:AZN)
sharemarketupdates.com - September 19 at 8:30 AM
News IconAstraZeneca plc (AZN) Raised to Buy at Jefferies Group - NewsDen (NYSE:AZN)
newsden.net - September 18 at 8:30 AM
News IconAstraZeneca plc (LON:AZN) Shares Lifted On Promising Type-2 Diabetes Drug Results - Simply Wall St (NYSE:AZN)
simplywall.st - September 17 at 8:33 AM
4-traders.com logoFTSE falls as banking stocks lose ground (NYSE:AZN)
www.4-traders.com - September 16 at 3:43 PM
uk.finance.yahoo.com logoBritain's FTSE falls as banking stocks lose ground (NYSE:AZN)
uk.finance.yahoo.com - September 16 at 3:43 PM
finance.yahoo.com logoPhase III Combination Trial of BYDUREON and FARXIGA Shows Significant Blood Sugar Reduction in Patients with Type 2 Diabetes (NYSE:AZN)
finance.yahoo.com - September 16 at 8:59 AM
News IconLarge Cap Drug Manufacturers – Major: AstraZeneca PLC (NYSE:AZN) (NYSE:AZN)
twincountynews.com - September 15 at 4:12 PM
investopedia.com logoThomas Mistele’s Q2 Healthcare Picks (AZN, CI) (NYSE:AZN)
www.investopedia.com - September 15 at 12:37 PM
publicnow.com logo15 September 2016 Opening up a treasure trove of new drug target opportunities (NYSE:AZN)
www.publicnow.com - September 15 at 12:36 PM
marketexclusive.com logoAstraZeneca Plc (NYSE:AZN) Launches 2 Forxiga Phase 3b ... - Market Exclusive (NYSE:AZN)
marketexclusive.com - September 14 at 3:43 PM
uk.finance.yahoo.com logoAspen Pharmacare moves into China as South Africa sales dip (NYSE:AZN)
uk.finance.yahoo.com - September 14 at 3:43 PM
News IconHC Stocks News Ring= Sanofi SA (ADR) (NYSE:SNY), AstraZeneca plc (ADR) (AZN) - share market updates (press release) (NYSE:AZN)
sharemarketupdates.com - September 13 at 4:06 PM
ft.com logo[$$] AstraZeneca climbs on cancer drugs pipeline hopes (NYSE:AZN)
www.ft.com - September 13 at 8:33 AM
wsj.com logoA Flu Shot Is the Best Defense This Year (NYSE:AZN)
www.wsj.com - September 13 at 8:33 AM
marketrealist.com logoPerformance of GSK’s Global Pharmaceuticals Franchises Mixed (NYSE:AZN)
marketrealist.com - September 13 at 8:33 AM
uk.finance.yahoo.com logoBUZZ-AstraZeneca: top FTSE 100 gainer on lung cancer drug hopes (NYSE:AZN)
uk.finance.yahoo.com - September 12 at 8:32 AM
thecountrycaller.com logoAstraZeneca plc's (ADR) (AZN) Future Seems Positive: Merrill Lynch - TCC (NYSE:AZN)
www.thecountrycaller.com - September 10 at 8:29 AM
publicnow.com logo24 August 2016 AstraZeneca to sell small molecule antibiotics business to Pfizer Corporate Press Release (NYSE:AZN)
www.publicnow.com - September 9 at 3:41 PM

Social

Astrazeneca PLC (NYSE:AZN) Chart for Saturday, October, 1, 2016


Last Updated on 10/1/2016 by MarketBeat.com Staff